Glaucoma Research Foundation hosted our 2018 Annual Dinner at the historic San Francisco War Memorial and Performing Arts Center on April 24, 2018.
Read More »The announcement came after researchers detected a dramatic rise in endothelial cell loss (ECL) among patients who received the CyPass microstent during cataract surgery 5 years ago, compared with patients who underwent cataract surgery alone.
Read More »Researchers say an autoimmune response may be behind the eye pressure and vision loss that sometimes precedes a glaucoma diagnosis.
Read More »In a small study, a combination over-the-counter supplement with antioxidant and mitoprotective properties significantly reversed mitochondrial dysfunction.
Read More »Study indicates treatment using insulin may restore vision in glaucoma patients. San Francisco, CA - July 31, 2018 - Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers,...
Read More »Aerie Pharmaceuticals has announced the launch of Rhopressa, a novel eye drop indicated for lowering elevated intraocular pressure in patients with glaucoma.
Read More »
GRF has announced the celebration of its 40th anniversary year, the board approval of its new strategic plan, and an expanded capital campaign designed to accelerate research towards a cure.
Read More »
The announcement during World Glaucoma Week emphasizes the need to find better treatments and a cure for this disease that affects more than 60 million people.
Read More »The 2018 Shaffer Prize was presented to Dr. Carla Siegfried during ceremonies at the Glaucoma 360 Annual Gala on February 8th at the Palace Hotel in San Francisco.
Read More »A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released in the Proceedings of the National Academy of Sciences (PNAS).
Read More »
